ArticleEJHaem2023

Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study.

Rosa Ayala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.